Here we present a case of a patient with inconclusive biopsy results whose CSF ctDNA revealed a MYD88 mutation suggestive of PCNSL and guided her treatment with high-dose methotrexate. This evidence concerns the gene MYD88 and primary central nervous system lymphoma.